Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Apr 28, 2019
Marina Baroff, Senior Director, Service Innovation at Steps Through OC shines a light on the need to provide physical as well as emotional support to women living with ovarian cancer and their caregivers. Marina talks about this new program of The Clearity Foundation with seed funding provided by the Susan Poorman...
Apr 22, 2019
Dr. Jay Venkatesan, CEO, Angion, a clinical stage biopharmaceutical company, discusses the company's work in organ self-repair and their initial focus in the nephrology space. The company's lead candidate ANG-3777 is a small molecule that mimics a protein to stimulate this self-repair and regeneration following injury....
Apr 15, 2019
William Annett, CEO, OncoCyte discusses the exciting work the company is doing in the liquid biopsy space. They have developed DetermaVu™ a liquid biopsy test for lung cancer, which studies show has the potential to detect the absence of cancer by analyzing a simple blood sample. This technique allows individuals...
Apr 8, 2019
Dr. Hartmut Ehrlich, CEO of Abivax discusses the exciting new progress that this French biotechnology company has observed in clinical trials of their most advanced clinical drug candidate, ABX464. Originally designed to treat HIV by reducing the viral reservoir, Abivax determined the molecule could also be...
Apr 1, 2019
Anna Landre is a Georgetown University sophomore who has a rare disease, spinal muscular atrophy (SMA) and is a wheelchair user. In addition to being a full time student, Anna serves as Commissioner of the Advisory Neighborhood Commission where she advocates for people with disabilities and to improve accessibility on...